Assignee
URTESTE S A
PL·0 granted patents·8 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
8 records- 0140US2026098058A1Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancerURTESTE S A·Filed 2023·Application pending·0 cites
- 0239US2025376711A1Compound-diagnostic marker for uterine body cancer, method for detecting enzymatic activity, method for diagnosis of uterine body cancer, kit comprising the compound, uses of the compound and method for the treatment of uterine body cancerURTESTE S A·Filed 2023·Application pending·0 cites
- 0338US2025206777A1Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancerURTESTE S A·Filed 2023·Application pending·0 cites
- 0438US2025270617A1Compound - diagnostic marker for kidney cancer, method for detecting enzymatic activity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancerURTESTE S A·Filed 2023·Application pending·0 cites
- 0536US2024353410A1Fret enzymatic substrate and uses thereof in liver cancerURTESTE S A·Filed 2022·Application pending·0 cites
- 0636US2025003970A1Fret enzymatic substrate and uses thereof in lung cancerURTESTE S A·Filed 2022·Application pending·0 cites
- 0730US2023204587A1Novel diagnostic marker for prostate cancerURTESTE S A·Filed 2021·Application pending·0 cites
- 0826US2022251625A1Novel diagnostic marker for pancreatic cancerURTESTE S A·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when URTESTE S A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →